PHF TAU IN NEURODEGENERATIVE DISEASE IN MICRONESIA
PHF TAU IN NEURODEGENERATIVE DISEASE IN MICRONESIA
批准号:
6267709
负责人:
VIRGINIA M LEE
金额:
$18.57万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-03-01 至 1999-02-28
中文摘要
与阿尔茨海默氏症类似的神经退行性疾病的患病率
帕金森病(PD)和肌萎缩侧索硬化症
(ALS)在马里亚纳群岛的查莫罗人中异常高。尽管
这些查莫罗人疾病(称为关岛ALSIPDC)和
其他地方的AD、PD或ALS,关岛ALS/PDC大脑的主要发现
与经典AD中的神经元缠结(NE;Ts)相似,存在大量神经元缠结。
例如,NFT AD和关岛ALS/PDC的主要结构要素
是成对的螺旋丝(PHF),以前的研究表明,
AD和关岛ALSIPDC中的PHF是由异常的
磷酸化tau蛋白(PHFtau)。尽管如此,我们发现活检
衍生的正常成人tau蛋白在几乎所有的
先前在AD PHFtau中鉴定的位点,尽管程度较低,
活组织检查衍生的正常人tau蛋白经历快速和选择性的
在PHFtau中异常保留的位点的去磷酸化。我们
还提供了数据,表明磷酸化的差异,
正常人tau相对于PHFtau的状态可能是由于受损的
AD脑内磷酸酶活性。蛋白磷酸酶2A
(PP 2A)与PHFtau未能进行有效的细胞内转录有关。
去磷酸化由于PP 2A使tau蛋白去磷酸化,
PP 2A的辅助亚基、催化亚基和调节亚基可能发挥重要作用,
在PHFtau的产生中起重要作用。虽然退化的
关岛的ALSIPDC神经元几乎完全与
NFT的积累和脑脊液中的TAN水平
(CSF)AD患者的发病率相对于对照组升高,
和PHFtau积累的生物学意义
对AD和关岛ALS/PDC的神经系统病变了解甚少。
因此,项目4将测试以下假设:
神经元损伤在神经元变性中起作用,
关岛ALS/PDC。为了实现这一目标,我们将评估
CSF tan水平升高的意义,检查PP 2A在
PHFtau和缠结形成的发病机制,并表征
大脑中缠结轴承与正常神经元的分子图谱
有和没有关岛ALS/PDC的患者。这些研究将提供
PHFtau发病机制的重要见解,
关岛ALS/PDC的病变,并阐明这些病变如何导致神经元
关岛ALS/PDC的损失。
英文摘要
The prevalence of neurodegenerative disorders similar to Alzheimer's
disease (AD), Parkinson's disease (PD) and Amyotrophic Lateral Sclerosis
(ALS) is unusually high among Chamorros in the Mariana Islands. Despite
similarities between these Chamorro diseases (known as Guam ALSIPDC) and
AD, PD or ALS elsewhere, the predominant findings in Guam ALS/PDC brains
are abundant neurofibrillary tangles (NE;Ts) like those in classic AD.
For example, the major structural elements of NFTs AD and Guam ALS/PDC
are paired helical filaments (PHFs), and previous studies showed that
the PHFs in AD and Guam ALSIPDC are formed from abnormally
phosphorylated tau proteins (PHFtau). Although, we showed that biopsy
derived normal adult human tau is phosphorylated at nearly all of the
sites previously identified in AD PHFtau, albeit to a lesser extent,
biopsy derived normal human tau undergoes rapid and selective
dephosphorylation at sites that are abnormally retained in PHFtau. We
also provided data to suggest that differences in the phosphorylation
state of normal human tau versus PHFtau may be due to impaired
phosphatase activity in the AD brain. Indeed, protein phosphatase 2A
(PP2A) was implicated in the failure of PHFtau to undergo efficient
dephosphorylation. Since PP2A dephosphorylates tau, alterations in the
accessory, catalytic and regulatory subunits of PP2A could play a
central role in the generation of PHFtau. Although the degeneration of
neurons in Guam ALSIPDC is associated almost exclusively with the
accumulation of NFTs, and the levels of tan in the cerebrospinal fluid
(CSF) of AD patients are elevated relative to controls, the pathogenesis
and biological significance of accumulations of PHFtau in
neurofibrillary lesions in AD and Guam ALS/PDC are poorly understood.
Thus, Project 4 will test the hypothesis that PHFtau-rich
neurofibrillary lesions play a role in the degeneration of neurons in
Guam ALS/PDC. To accomplish this, we will assess the biological
significance of elevated levels of CSF tan, examine the role of PP2A in
the pathogenesis of PHFtau and tangle formation, and characterize the
molecular profile of tangle bearing versus normal neurons in the brains
of patients with and without Guam ALS/PDC. These studies will provide
important insights into the pathogenesis of PHFtau in the hallmark
lesions of Guam ALS/PDC, and clarify how these lesions lead to neuron
loss in Guam ALS/PDC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pathogenesis of Tauopathies
-
批准号:10583338
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2023
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10373920
-
项目类别:
-
资助金额:$45.27万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
-
批准号:10654792
-
项目类别:
-
资助金额:$362.24万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10452562
-
项目类别:
-
资助金额:$67.03万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10020334
-
项目类别:
-
资助金额:$52.07万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
-
批准号:10452557
-
项目类别:
-
资助金额:$362.24万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Examining neuronal resilience in a mouse model of sporadic ALS
-
批准号:10610826
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Center On Alpha-synuclein Strains In Alzheimer Disease & Related Dementias
-
批准号:10373915
-
项目类别:
-
资助金额:$362.15万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Project I "Mechanisms of Pathological aSyn Transmission"
-
批准号:10654801
-
项目类别:
-
资助金额:$52.23万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
Examining neuronal resilience in a mouse model of sporadic ALS
-
批准号:10381720
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2019
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8534672
-
项目类别:
-
资助金额:$109.35万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8723014
-
项目类别:
-
资助金额:$115.72万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8144829
-
项目类别:
-
资助金额:$116.68万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:7763551
-
项目类别:
-
资助金额:$118.74万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
TDP-43 Proteinopathies in ALS-Dementia
-
批准号:8318125
-
项目类别:
-
资助金额:$115.72万
-
财政年份:2010
-
负责人:VIRGINIA M LEE
-
依托单位:
CORE--NEUROSCIENCE CORE
-
批准号:7492145
-
项目类别:
-
资助金额:$29.56万
-
财政年份:2007
-
负责人:VIRGINIA M LEE
-
依托单位:
NOVEL AB FRAGMENTS AS MEDIATORS OF ALZHEIMERS DISEASE
-
批准号:7492141
-
项目类别:
-
资助金额:$21.61万
-
财政年份:2007
-
负责人:VIRGINIA M LEE
-
依托单位:
Administrative Core
-
批准号:7498191
-
项目类别:
-
资助金额:$6.3万
-
财政年份:2007
-
负责人:VIRGINIA M LEE
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:6870600
-
项目类别:
-
资助金额:$6.57万
-
财政年份:2005
-
负责人:VIRGINIA M LEE
-
依托单位:
Biochemical and Immunohistochemical Analysis of FTDs
-
批准号:6851877
-
项目类别:
-
资助金额:$31.32万
-
财政年份:2005
-
负责人:VIRGINIA M LEE
-
依托单位:
海外基金